Technology area: Biotechnology & Pharmaceuticals
41 pending office actions • 33 art units • 39 examiners • 0 of 41 (0%) have an AI response strategy ready • 44 patents granted in the last 365 days
The University of Hong Kong has 44 pending office actions in Biotechnology & Pharmaceuticals. The matters span 42 distinct examiners and 36 distinct art units, indicating a broad and distributed prosecution docket with repeated assignments at both levels.
MEJIAS, SAMANTHA LEE is the busiest examiner, with 2 pending matters. The modest concentration around that examiner does not replace the need for portfolio-level coordination. Counsel should organize review by art unit and examiner while preserving matter-specific analysis for the larger docket.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (10%) |
| §103 only | 6 (15%) |
| §112 only | 2 (5%) |
| Double-patenting + other | 3 (7%) |
| Multi-statute (no §101) | 26 (63%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MEJIAS, SAMANTHA LEE | 2 | 46.7% | +40.0% |
| WANG, RUIXUE | 2 | 55.9% | +19.0% |
| SHAH, UTPAL D | 1 | 87.8% | +11.4% |
| SUN, CAITLYN MINGYUN | 1 | 63.7% | +11.8% |
| SARCENO ROBLES, CHRISTIAN MANUEL | 1 | 50.0% | +100.0% |
| ROSSI, JULIA ANNE LORRAIN | 1 | 45.7% | +61.3% |
| SHAH, JAY B | 1 | 58.4% | +6.0% |
| WANG, YUEHAN | 1 | 82.4% | +14.0% |
| MARVICH, MARIA | 1 | 55.0% | +28.0% |
| IANNUZO, NATALIE NMN | 1 | 12.2% | +71.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18995126 | A METHOD FOR PLACE RECOGNITION ON 3D POINT CLOUD | SHAH, UTPAL D | — |
| 18841600 | SYSTEM AND METHODS FOR QUANTIFYING AND CALCULATING WINDOW VIEW OPENNESS INDEXES | WANG, YUEHAN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18476499 | SYSTEM AND METHOD FOR ADDITION AND SUBTRACTION IN MEMRISTOR-BASED IN-MEMORY COMPUTING | NGUYEN, VAN THU T | 44d overdue |
| 17048297 | IMMUNO-ONCOLYTIC MODIFIED VACCINIA TIAN TAN VIRUS AND METHODS OF TREATING CANCER | WANG, RUIXUE | 31d overdue |
| 17625665 | COMPOSITIONS AND METHODS FOR CLEARING TISSUE | BARRON, SEAN C | 11d overdue |
| 18461081 | NIDOGEN 1 AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET OF HEPATOCELLULAR CARCINOMA, COMPOSITION AND METHODS THEREOF | SULLIVAN, DENNIS JOHN | 27d |
| 18621152 | TRANSCORNEAL STIMULATOR FOR TREATING BRAIN DISEASES | SCHAETZLE, KENNEDY | 48d |
| 18157725 | Micro Scale Mist Mouthguard Cleaning Device | MORAN, EDWARD JOHN | 56d |
| 17729584 | SURGERY DEVICE WITH PATIENT-SPECIFIC FIBULA MALLEOLUS CAP | HU, ANN M | 72d |
| 18969502 | FLEXIBLE MICRO-NEEDLE ELECTRODE FOR BIOPOTENTIAL MONITORING, A METHOD FOR CONSTRUCTING THE FLEXIBLE MICRO-NEEDLE ELECTRODE AND A PATCH ELECTRODE COMPRISING THE FLEXIBLE MICRO-NEEDLE ELECTRODE | SARCENO ROBLES, CHRISTIAN MANUEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17048297 | IMMUNO-ONCOLYTIC MODIFIED VACCINIA TIAN TAN VIRUS AND METHODS OF TREATING CANCER | WANG, RUIXUE | 31d overdue |
| 18995126 | A METHOD FOR PLACE RECOGNITION ON 3D POINT CLOUD | SHAH, UTPAL D | — |
| 18879269 | REGULATING THE ELECTROCHEMICAL REDOX BEHAVIOR OF SEMICONDUCTING POLYMERS ON SOFT AND STRETCHABLE SUBSTRATES AND METHODS OF USE | SUN, CAITLYN MINGYUN | — |
| 18969502 | FLEXIBLE MICRO-NEEDLE ELECTRODE FOR BIOPOTENTIAL MONITORING, A METHOD FOR CONSTRUCTING THE FLEXIBLE MICRO-NEEDLE ELECTRODE AND A PATCH ELECTRODE COMPRISING THE FLEXIBLE MICRO-NEEDLE ELECTRODE | SARCENO ROBLES, CHRISTIAN MANUEL | — |
| 18889021 | BIOMIMETIC INTRAOCULAR DRUG DELIVERY SYSTEM FOR TREATMENT OF RETINOBLASTOMA AND METHODS THEREOF | ROSSI, JULIA ANNE LORRAIN | — |
| 18841600 | SYSTEM AND METHODS FOR QUANTIFYING AND CALCULATING WINDOW VIEW OPENNESS INDEXES | WANG, YUEHAN | — |
| 18748156 | HYPOVENTILATION PHYSICAL MODELS AND APPLICATIONS THEREOF | MARVICH, MARIA | — |
| 18737027 | TRIPLET-TRIPLET ENERGY TRANSFER WITH LIGHT EXCITATION AT LONG WAVELENGTHS AND METHODS THEREOF | MEJIAS, SAMANTHA LEE | — |
| Art Unit | Apps |
|---|---|
| 1634 | 2 |
| 1653 | 2 |
| 1678 | 2 |
| 1658 | 2 |
| 1672 | 2 |
| 2668 | 1 |
| 1795 | 1 |
| 3794 | 1 |
| 1615 | 1 |
| 2617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18995126 | A METHOD FOR PLACE RECOGNITION ON 3D POINT CLOUD | SHAH, UTPAL D | 2668 | §103 | Non-Final OA | — | Pending | Jan 15, 2025 |
| 18879269 | REGULATING THE ELECTROCHEMICAL REDOX BEHAVIOR OF SEMICONDUCTING POLYMERS ON SOFT AND STRETCHABLE SUBSTRATES AND METHODS OF USE | SUN, CAITLYN MINGYUN | 1795 | §103 | Non-Final OA | — | Pending | Dec 27, 2024 |
| 18969502 | FLEXIBLE MICRO-NEEDLE ELECTRODE FOR BIOPOTENTIAL MONITORING, A METHOD FOR CONSTRUCTING THE FLEXIBLE MICRO-NEEDLE ELECTRODE AND A PATCH ELECTRODE COMPRISING THE FLEXIBLE MICRO-NEEDLE ELECTRODE | SARCENO ROBLES, CHRISTIAN MANUEL | 3794 | §102§103 | Non-Final OA | — | Pending | Dec 05, 2024 |
| 18889021 | BIOMIMETIC INTRAOCULAR DRUG DELIVERY SYSTEM FOR TREATMENT OF RETINOBLASTOMA AND METHODS THEREOF | ROSSI, JULIA ANNE LORRAIN | 1615 | §103§112 | Non-Final OA | — | Pending | Sep 18, 2024 |
| 18818762 | COIN-SIZED, FULLY INTEGRATED AND MINIMALLY INVASIVE CONTINUOUS GLUCOSE MONITORING SYSTEM (CGMs) BASED ON ORGANIC ELECTROCHEMICAL TRANSISTORS | SHAH, JAY B | — | §112 | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18841600 | SYSTEM AND METHODS FOR QUANTIFYING AND CALCULATING WINDOW VIEW OPENNESS INDEXES | WANG, YUEHAN | 2617 | §103 | Non-Final OA | — | Pending | Aug 26, 2024 |
| 18748156 | HYPOVENTILATION PHYSICAL MODELS AND APPLICATIONS THEREOF | MARVICH, MARIA | 1634 | §112 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18737027 | TRIPLET-TRIPLET ENERGY TRANSFER WITH LIGHT EXCITATION AT LONG WAVELENGTHS AND METHODS THEREOF | MEJIAS, SAMANTHA LEE | — | §103§112Other | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18653590 | OCULAR ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | IANNUZO, NATALIE NMN | 1653 | §103§112 | Non-Final OA | — | Pending | May 02, 2024 |
| 18702650 | PHOTOCLEAVABLE PRODRUG-BASED NANOMEDICINE FOR IN-SITU MONITORABLE CANCER THERAPY | MEJIAS, SAMANTHA LEE | — | §102§103Other | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18621152 | TRANSCORNEAL STIMULATOR FOR TREATING BRAIN DISEASES | SCHAETZLE, KENNEDY | 3796 | §101§102§103 | Final Rejection | 48d | Pending | Mar 29, 2024 |
| 18608983 | MACHINE LEARNING-BASED IMAGE PROCESSOR FOR INTRAORAL IMAGES | SHARIFF, MICHAEL ADAM | 2672 | §103 | Final Rejection | 42d | Pending | Mar 19, 2024 |
| 18600046 | MODIFIED O-METHYLTRANSFERASES USEFUL FOR PRODUCTION OF O-METHYLATED PHENOLIC NATURAL PRODUCTS | HUTSON, RICHARD G | 1652 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18597181 | SYSTEM COMPRISING CISPLATIN-RESISTANT XENOGRAFT FOR NASOPHARYNGEAL CARCINOMA AND METHODS THEREOF | PENNINGTON, KATIE LEIGH | 1634 | §102§103§112 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18596220 | Self-Powered Smart Skins for Multimodal Static and Dynamic Tactile Perception | BARBEE, MANUEL L | 2857 | §103§112 | Non-Final OA | — | Pending | Mar 05, 2024 |
| 18682313 | SILVER COMPLEX FLUORIDE {BIS (1,3,5-TRIAZA-7-PHOSPHAADAMANTANE) SILVER FLUORIDE} - A NEW THERAPEUTIC AGENT FOR CARIES MANAGEMENT | PETRITSCH, AMANDA MICHELLE | 1612 | §103§112 | Final Rejection | — | Pending | Feb 08, 2024 |
| 18681271 | COMPOSITIONS AND METHODS FOR FAST MULTIPLEXED SCREENING AND MONITORING OF NPM1 MUTATIONS | KAPUSHOC, STEPHEN THOMAS | 1683 | §102§103§112 | Non-Final OA | — | Pending | Feb 05, 2024 |
| 18538932 | SEQUENTIAL TRANSARTERIAL CHEMOEMBOLIZATION, STEREOTACTIC BODY RADIOTHERAPY, AND IMMUNOTHERAPY (START-FIT) FOR HEPATOCELLULAR CARCINOMA | MIDDLETON, DANAYA L | 4100 | §102§103§112 | Non-Final OA | — | Pending | Dec 13, 2023 |
| 18569361 | ROS-RESPONSIVE CAPTOPRIL-CINNAMALDEHYDE PRODRUGS AND COMPOSITIONS AND METHODS THEREOF | CHANDRAKUMAR, NIZAL S | 1625 | §102§112Other | Non-Final OA | — | Pending | Dec 12, 2023 |
| 18566491 | FIBROSIS BIOMARKERS FOR NON-ALCOHOLIC FATTY LIVER DISEASE | SVEIVEN, MICHAEL CAMERON | 1678 | §101§102§103§112 | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18560347 | COMPOSITIONS AND METHODS OF TARGETING THE PAX6 SIGNALING PATHWAY TO REDUCE FORMATION OF AMYLOID BETA PLAQUES AND NEUROFIBRILLARY TANGLES | GIBBS, TERRA C | 1635 | §103§112 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18476499 | SYSTEM AND METHOD FOR ADDITION AND SUBTRACTION IN MEMRISTOR-BASED IN-MEMORY COMPUTING | NGUYEN, VAN THU T | 2824 | §102§112 | Non-Final OA | 44d overdue | Pending | Sep 28, 2023 |
| 18551504 | LUMINESCENT GOLD (III) COMPOUNDS WITH THERMALLY ACTIVATED DELAYED FLUORESCENCE (TADF) AND THERMALLY STIMULATED DELAYED PHOSPHORESCENCE (TSDP) PROPERTIES FOR ORGANIC LIGHT-EMITTING DEVICES AND THEIR PREPARATION | HIGGINS, GERARD T | 1785 | §103§112 | Non-Final OA | — | Pending | Sep 20, 2023 |
| 18461081 | NIDOGEN 1 AS A DIAGNOSTIC MARKER AND THERAPEUTIC TARGET OF HEPATOCELLULAR CARCINOMA, COMPOSITION AND METHODS THEREOF | SULLIVAN, DENNIS JOHN | 1642 | §101§112 | Final Rejection | 27d | Pending | Sep 05, 2023 |
| 18264695 | CELL NICHE ENGINEERING PLATFORM, MULTIPLEXED BIOCHIPS RESULTING THEREFROM AND METHODS OF USE THEREOF | HASSAN, LIBAN M | 1799 | §102§103§112 | Non-Final OA | — | Pending | Aug 08, 2023 |
| 18270069 | A BIOMATERIAL WITH A HIGH GLYCOSAMINOGLYCAN/HYDROXYPROLINE RATIO, COMPOSITION, METHODS AND APPLICATIONS | CRAIGO, BAHAR ALAWI | 1699 | §102§103§112 | Non-Final OA | — | Pending | Jun 28, 2023 |
| 18037407 | TRANSPARENT AND HIGH-K THIN FILM PREPARED BY PULSED LASER DEPOSITION | MCCLURE, CHRISTINA D | 1718 | §103 | Final Rejection | — | Pending | May 17, 2023 |
| 18251374 | TRANSFERABLE TYPE I-F CRISPR-CAS GENOME EDITING SYSTEM | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103§112 | Final Rejection | — | Pending | May 01, 2023 |
| 18249926 | COMPOSITIONS OF ANTI-VIRAL PEPTIDES AND/OR COMPOUNDS AND METHODS OF USE THEREOF | KATAKAM, SUDHAKAR | 1658 | §112DP | Non-Final OA | — | Pending | Apr 20, 2023 |
| 18185449 | DISCOVERY OF YEATS2 YEATS DOMAIN INHIBITORS AS NOVEL ANTI-CANCER AGENTS | HIBBERT, CATHERINE S | 1658 | §102§112 | Non-Final OA | — | Pending | Mar 17, 2023 |
| 18170296 | COMPOSITIONS AND METHODS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY | HUMPHRIES, NICHOLAS ADAM | 1631 | §102§103§112 | Non-Final OA | — | Pending | Feb 16, 2023 |
| 18006977 | GENETICALLY ENCODED YEATS DOMAIN PROBE AND APPLICATIONS THEREOF | TSAY, MARSHA M | 1656 | §103 | Non-Final OA | — | Pending | Jan 26, 2023 |
| 18157725 | Micro Scale Mist Mouthguard Cleaning Device | MORAN, EDWARD JOHN | 3772 | §103§112 | Final Rejection | 56d | Pending | Jan 20, 2023 |
| 17996287 | IDENTIFICATION OF NSP1 GENE AS TARGET OF SARS-COV-2 REAL-TIME RT-PCR USING NANOPORE WHOLE GENOME SEQUENCING | WANG, RUIXUE | 1672 | §103§112 | Final Rejection | — | Pending | Oct 14, 2022 |
| 17996165 | SYSTEM FOR THREE-WAY COMBINATORIAL CRISPR SCREENS FOR ANALYSING TARGET INTERACTIONS AND METHODS THEREOF | WARD, AARON DUREL | 1636 | §103§112 | Non-Final OA | — | Pending | Oct 13, 2022 |
| 17850720 | COMPOSITIONS AND METHODS FOR OPTOCHEMICAL CONTROL OF MTOR SIGNALING AND MTOR-DEPENDENT AUTOPHAGY | NOTTINGHAM, KYLE GREGORY | 1621 | §103§112 | Final Rejection | — | Pending | Jun 27, 2022 |
| 17729584 | SURGERY DEVICE WITH PATIENT-SPECIFIC FIBULA MALLEOLUS CAP | HU, ANN M | 3774 | §102§103 | Final Rejection | 72d | Pending | Apr 26, 2022 |
| 17625665 | COMPOSITIONS AND METHODS FOR CLEARING TISSUE | BARRON, SEAN C | 1653 | §103§112 | Final Rejection | 11d overdue | Pending | Jan 07, 2022 |
| 17435943 | CULTURE MEDIUM FOR MAMMALIAN EXPANDED POTENTIAL STEM CELLS, COMPOSITION, AND METHODS THEREOF | REGLAS, GILLIAN CHELSEA | 1632 | §103DP | Non-Final OA | — | Pending | Sep 02, 2021 |
| 17265756 | COMPOSITIONS AND METHODS FOR DETECTION AND IMAGING OF AMYLOID FIBRILS, AMYLOID PLAQUES, RNA, AND NUCLEOLI | NGUYEN, NAM P | 1678 | §102§103§112DP | Final Rejection | 43d overdue | Pending | Feb 03, 2021 |
| 17048297 | IMMUNO-ONCOLYTIC MODIFIED VACCINIA TIAN TAN VIRUS AND METHODS OF TREATING CANCER | WANG, RUIXUE | 1672 | §103§112 | Non-Final OA | 31d overdue | Pending | Oct 16, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe University of Hong Kong has 41 pending office actions as of October 2026, spread across 33 art units and 39 examiners.
Samantha Lee Mejias has the most, with 2 of The University of Hong Kong's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
